Cefazolin EP Impurity H

IMPURITIES

Product Details

CAT No.# CS-T-02193
Category Impurities
CAS 957-68-6
Molecular Weight 272.28
Molecular Formula C10H12N2O5S
Stock Status: In-Stock
Purity: >98
Synonyms: CS-O-13461; 7-Aminocephalosporanic acid; (6R,7R)-3-thia-1-az2-ene-2-carboxylic acid;213-485-0;7-Aminocephalosporanic Acid ("7-ACA") ;Cefoperazone EP Impurity E; Cefalotin EP Impurity C
Application Notes: Impurity in commercial preparations of Cefazolin.
References: Katzung, et. al., Bertram (2015); Stork, CM (2006)
Storage: Keep in a tightly closed vial, store in refrigerator
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. 1-(3-hydroxypropyl)-4-(3-chloropropyl) piperazine
2. Trazodone Impurity G
3. 2-(3,5-dimethyl-1H-pyrazol-1-yl)-4,6-dimethylpyrimidin-5-ol
4. (1-(4,6-dimethylpyrimidin-2-yl)-3-methyl-1H-pyrazol-5-yl)methanol
5. (1-(4,6-dimethylpyrimidin-2-yl)-5-methyl-1H-pyrazol-3-yl)methanol
6. 2-(3-(hydroxymethyl)-5-methyl-1H-pyrazol-1-yl)-4,6-dimethylpyrimidin-5-ol
7. 2-(3-(hydroxymethyl)-5-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-ol
8. 1-(2-HYDROXYPHENYL)-3-PHENYLHEXANE-1,5-DIONE
9. 1-(4,6-dimethylpyrimidin-2-yl)-3,5-dimethyl-1H-pyrazol-4-yl hydrogen sulfate
10. 1-(4,6-dimethylpyrimidin-2-yl)-3-methyl-1H-pyrazole-5-carboxylic acid
11. Trimetazidine N-Oxide
12. Phenylephrine EP Impurity E
13. (2S,3S,4S,5R,6R)-6-((1-(4,6-dimethylpyrimidin-2-yl)-5-methyl-1H-pyrazol-3-yl)methoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
14. 2,4-dichloro-5-sulfamoylbenzamide
15. Brivaracetam Carboxylic acid metabolite [UCB 42145]
16. Sodium methanethiolate (S-34)
17. Thiourea S-34
18. rel-(1R)-2-Amino-1-((2S)-6-fluorochroman-2-yl)ethanol
19. rel-N-Benzyl Nebivolol
20. Olsalazine sodium for performance test (O0146010)


SMILES:
CC(OCC(CS[C@@]([H])(N12)[C@H](N)C2=O)=C1C(O)=O)=O



This page contains information about Cefazolin EP Impurity H Cas 957-68-6 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."